Kidney Cancer Treatments: Options, Stages, and What to Expect

Comprehensive guide to kidney cancer treatments, their effectiveness by stage, types of therapies, and support options.

By Sneha Tete, Integrated MA, Certified Relationship Coach
Created on

Kidney cancer is among the ten most diagnosed cancers worldwide, affecting both men and women. Medical advances have led to a variety of effective treatments, with options tailored to the stage and type of cancer, the individual’s overall health, and other important factors. This guide covers all available treatments for kidney cancer, how these therapies are chosen by stage, the medical experts involved, and where to find essential support resources.

Overview: Understanding Kidney Cancer and Its Treatment Paths

Kidney cancer most often originates in the cells of the kidneys—vital organs responsible for filtering blood and balancing fluids. The disease’s progression is categorized into stages, which play a crucial role in determining the most appropriate form of treatment. Other considerations include the cancer subtype, tumor grade, your general health, and potential impact on kidney function.

Common objectives of kidney cancer treatment are:

Understanding how prognosis varies by stage is crucial in managing kidney cancer effectively. Each patient's journey is unique, and knowing what to expect can provide peace of mind. For a deeper insight into survival rates and the influencing factors at each stage, you can explore our detailed guide on Kidney Cancer Prognosis by Stage.
  • Removing cancer from the body
  • Preventing recurrence
  • Managing symptoms and improving quality of life

Treatment plans are often personalized, using one or more types of healthcare professionals such as urologists, oncologists, and nephrologists.

Kidney Cancer Treatments by Stage

Treatment for kidney cancer varies based on how advanced the disease is at diagnosis. Staging involves assessing whether the cancer is confined to the kidney (localized), has spread to nearby tissues or lymph nodes (locally advanced), or has metastasized to distant organs.

The following table summarizes typical treatments by stage:

StageCommon Treatments
Stage 1Active surveillance, ablation, surgery (partial or radical nephrectomy)
Stage 2Surgery, targeted therapy, immunotherapy
Stage 3Surgery, targeted therapy, immunotherapy
Stage 4Surgery, targeted therapy, immunotherapy, radiation therapy, chemotherapy
It's essential to understand the specifics of renal cell carcinoma, the most common type of kidney cancer. This knowledge can empower patients and caregivers to make informed decisions about treatment options. Consider reading our comprehensive guide to Understanding Renal Cell Carcinoma, providing invaluable insights on this critical topic.

Doctors often use a combination of these therapies, depending on the specific case and disease characteristics.

Active Surveillance: Watchful Waiting for Early, Low-Risk Cancers

Active surveillance may be recommended for small, slow-growing kidney tumors—especially in older adults or those with other significant health issues. Instead of immediate treatment, the cancer is closely monitored using regular imaging tests and check-ups. If signs of progression develop, active treatment can begin.

Key benefits:

  • Avoids unnecessary treatment side effects
  • Preserves kidney function as long as possible

Ablation: Destroying Small Tumors Without Surgery

Ablation therapies offer a minimally invasive option for some people who cannot undergo or wish to avoid traditional surgery. Two main types are:

When assessing your treatment options, comparing ablation and traditional surgery is vital. Both methods have their unique advantages and risks. To help you make an educated choice, dive into our comparison of Ablation vs. Surgery for Kidney Cancer, which details the benefits and considerations for each method.
  • Radiofrequency ablation: Uses high-energy radio waves to heat and destroy cancer cells.
  • Cryoablation: Uses cycles of cold temperatures to freeze and kill cancer cells.

These procedures are usually performed with image guidance and sedation, and are mainly used for small, localized tumors (<4 cm).

Surgery: The Mainstay of Kidney Cancer Treatment

Surgery remains the most common and effective treatment for kidney cancer, especially in early stages. There are two major surgical approaches:

  • Partial nephrectomy: Only the tumor and a small section of healthy tissue are removed, preserving most of the kidney. Preferred for small tumors and when kidney function needs to be preserved.
  • Radical nephrectomy: Removal of the entire kidney, often with nearby tissues, adrenal gland, and possibly lymph nodes. Usually done for larger or more extensive tumors.
Moreover, understanding the medications available for kidney cancer can significantly enhance treatment outcomes. Different drugs play critical roles in various stages of treatment from surgery recovery to advanced care. Get informed by checking out our comprehensive guide on Medications for Treating Kidney Cancer.

Most people can live a normal life with one healthy kidney. The surgical approach may vary (open, laparoscopic, or robotic-assisted) based on tumor size, location, and overall health.

Targeted Therapy for Kidney Cancer

Targeted therapies use drugs designed to disrupt specific proteins and pathways that cancer cells use to grow and survive. Unlike traditional chemotherapy, which affects all rapidly dividing cells, targeted therapies are more selective, focusing specifically on cancer-related mechanisms.

Most targeted drugs for kidney cancer work by interrupting the formation of new blood vessels (angiogenesis) or by blocking the action of proteins involved in cell growth, such as VEGF (vascular endothelial growth factor) or mTOR (mammalian target of rapamycin).

Staying informed about the latest targeted therapies can significantly impact treatment effectiveness. These treatments are tailored to interfere with cancer cell functions on a molecular level. To comprehend how these options may fit into your treatment plan, check out our Complete Guide to Medications for Treating Kidney Cancer, an essential resource for every patient and caregiver.

Common targeted therapy drugs for kidney cancer:

  • Axitinib (Inlyta)
  • Belzutifan (Welireg)
  • Bevacizumab (Avastin)
  • Cabozantinib (Cabometyx)
  • Lenvatinib (Lenvima)
  • Pazopanib (Votrient)
  • Sorafenib (Nexavar)
  • Sunitinib (Sutent)
  • Tivozanib (Fotivda)
  • mTOR inhibitors, including Everolimus (Afinitor) and Temsirolimus (Torisel)

Targeted therapy is especially important in advanced or metastatic kidney cancer—when the disease has spread beyond the kidney. Sometimes, they are used after surgery (as adjuvant therapy) to minimize the risk of recurrence.

Immunotherapy: Boosting the Body’s Defenses Against Cancer

Immunotherapy is an innovative treatment that helps the immune system recognize and destroy cancer cells. Immune checkpoint inhibitors are the central drugs in this category for kidney cancer. They work by blocking proteins that prevent immune cells from attacking cancer.

Common immunotherapy drugs used in kidney cancer include:

Immunotherapy represents a groundbreaking approach to empower your body's own immune system against cancer. Understanding the specific immunotherapy options available can be a game-changer in your treatment journey. For a thorough overview of the choices you have, consult our Comprehensive Guide to Immunotherapy Options for Kidney Cancer, which can provide the insights needed for informed decision-making.
  • Nivolumab (Opdivo)
  • Pembrolizumab (Keytruda)
  • Ipilimumab (Yervoy)

Immunotherapies may be combined with targeted drugs or surgery to improve outcomes, particularly for advanced cancers or those at high risk of recurrence after surgery.

Radiation Therapy: Targeted Energy to Control Symptoms

Radiation therapy involves using focused high-energy beams (such as X-rays) to destroy cancer cells. While not typically used as a first-line treatment for primary kidney tumors, it can be employed to:

  • Alleviate pain or bleeding from cancer that has spread to other body parts (palliative care)
  • Treat patients who cannot undergo surgery due to overall health or have only one kidney

Radiation is generally used for symptom control, not for curing kidney cancer.

Chemotherapy: Limited Role in Kidney Cancer

Chemotherapy is less commonly used for kidney cancer because most types are resistant to standard chemotherapy drugs. However, in rare cases—especially with non-clear cell subtypes, advanced disease, or when other therapies fail—chemotherapy may be considered.

Commonly used chemotherapy drugs include:

  • Gemcitabine
  • 5-fluorouracil (5-FU)

Chemotherapy drugs are typically given intravenously or by mouth and may be used in combination for increased effectiveness.

Kidney Cancer Treatment Experts

A multidisciplinary team is often involved in diagnosing and managing kidney cancer, including:

  • Urologists: Surgeons who specialize in urinary tract diseases and perform kidney cancer surgeries.
  • Medical oncologists: Physicians specializing in treating cancer with medication (such as targeted therapy and immunotherapy).
  • Radiation oncologists: Experts who design and deliver radiation therapy protocols.
  • Nephrologists: Kidney health specialists who help manage kidney function before, during, and after treatment.
  • Nurse navigators and counselors: Provide support and help patients coordinate treatment and address psychological needs.

Finding Support: Resources for Patients and Caregivers

A kidney cancer diagnosis can be emotionally and physically overwhelming. Support resources help patients and families cope with anxiety, depression, logistical issues, and financial concerns. Some valuable support options include:

  • Patient advocacy groups and foundations for kidney cancer
  • Hospital and clinic social workers
  • Professional counseling and mental health services
  • Peer support groups (in-person and online)

Participating in a support network can improve emotional well-being and help patients make informed decisions throughout treatment and survivorship.

Frequently Asked Questions (FAQs) About Kidney Cancer Treatment

What is the most common treatment for early-stage kidney cancer?

Surgery, either partial or radical nephrectomy, is the primary and often curative option for early-stage kidney cancer. In select cases involving small tumors, active surveillance or ablation may be considered.

Can kidney cancer be treated without removing the kidney?

Yes. Partial nephrectomy (removal of just the tumor), ablation, and in some cases active surveillance are treatment options that can preserve kidney tissue and function.

How effective is targeted therapy for kidney cancer?

Targeted therapies have improved outcomes for people with advanced or metastatic disease. They may provide a survival benefit over traditional non-targeted therapies but are rarely curative when used alone.

Is chemotherapy commonly used for kidney cancer?

Chemotherapy plays a limited role in treating kidney cancer, mainly reserved for special situations such as certain rare subtypes or when other treatments are ineffective.

What are the main concerns after kidney cancer treatment?

Follow-up care focuses on monitoring for recurrence, managing side effects, preserving kidney function, and optimizing quality of life. Emotional and psychological support is also vital as part of recovery.

Takeaway: Key Points About Kidney Cancer Treatment

  • Most kidney cancers are treatable, especially when diagnosed early.
  • Multiple treatment options exist; the best approach is tailored to the individual.
  • Surgery is the mainstay for localized disease, while targeted and immune therapies help manage advanced or recurrent cancer.
  • Support from a skilled medical team and patient advocacy resources contributes significantly to recovery and well-being.
Sneha Tete
Sneha TeteBeauty & Lifestyle Writer
Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to thebridalbox, crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete